GEHC Stock Analysis: Buy, Sell, or Hold?
GEHC - GE HealthCare Technologies Inc. Common Stock
$64.70
0.00 (0.00%)
▲
5d:
-1.32%
30d:
-1.98%
90d:
-11.26%
BUY
HIGH Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Jul 29, 2026
15d
Smart Money Accumulation
None View Scanner →
Strength: 4.5/10
Get Alerted When GEHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GEHC trading at deep discount. Market pricing in -4.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: GEHC trading at deep discount. Market pricing in -4.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$103.95
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$64.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GEHC is currently trading at $64.70, which is considered fair relative to its 30-day fair value range of $62.65 to $65.44. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.1) compared to its historical average (13.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, GEHC is in a strong downtrend. The price is currently testing key support at $63.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GEHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $78.95 (+22.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GEHC is in a strong downtrend. The price is currently testing key support at $63.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GEHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $78.95 (+22.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$62.65 -
$65.44
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.0% below Wall St target ($78.95)
Trading Range Analysis
30-Day Trading Range
$62.65 -
$65.44
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$63.06
Resistance Level
$66.45
Current Trend
Strong Downtrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.06
Wall Street Target
$78.95
(+22.0%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
-30.9%
Profit Margin
9.1%
Valuation Discount vs History
-4.5% cheaper
PE vs Historical
12.1 vs 13.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.5%
(market-implied from PE analysis)
1-Year Target
$61.79
(-5%)
2-Year Target
$59.01
(-9%)
3-Year Target
$56.35
(-13%)
3-Yr Target (if PE normalizes)
(PE: 12→14)
$64.47
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.1%)
$155.76
(+141%)
Base:
(SPY PE: 12.1, Growth: 10.1%)
$86.27
(+33%)
Bear:
(PE: 10.3, Growth: 10.1%)
$73.33
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 15.52 | Current EPS (TTM): $4.17
Bull Case
$91.54
(+42%)
Analyst growth 28.6%, PE expands to 17.1
Base Case
$83.22
(+29%)
Market implied 28.6%, PE stable at 15.5
Bear Case
$44.00
(-32%)
Severe decline -20.0%, PE contracts to 13.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.1 to 13.8
Stabilization Target:
$74.02
(+14.4%)
PE Expansion Potential:
+14.4%
Share & Embed Analysis
Last updated: July 13, 2026 9:04 AM ET
Data refreshes hourly during market hours. Next update: 10:04 AM
Data refreshes hourly during market hours. Next update: 10:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GEHC showing a specific setup today?
Insider Activity (6 Months)
2
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Terri A. Sewell
SELL
2026-03-25
Warren Davidson
SELL
2026-03-23
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
Advanced GEHC Option Strategies
Professional options setups generated by AI based on today's GEHC price and gamma walls.
